In a Brazilian cohort of breast cancer patients and controls, the FTO SNPs rs1121980 and rs9939609, in combination with the melanocortin-4 receptor (MC4R) SNP rs17782313, were linked with an increased risk of breast cancer by 4.59-fold [57]. This evidence concerns the gene FTO and breast carcinoma.